Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This is a routine maintenance update that does not change study details or how the page works.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of v3.6.3. This appears to be a minor site/template update and does not modify study data.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe study record page revision tag was updated to v3.6.3, indicating a newer release of the page.SummaryDifference0.1%

- Check63 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'. The page now shows a recruitment status note ('No longer looking for participants') and updates the site revision to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check70 days agoChange DetectedThe page displays Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated version of the page content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page now displays Revision: v3.5.4, signaling a minor update to the page's release or documentation and not altering substantive information presented to users.SummaryDifference0.1%

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.